United Therapeutics | Gastos De Venta Y Administración



Selling And Administration Expenses Cambio Fecha
Amarin USD 36.9M 1.64M 2024-09
Ardelyx USD 76.07M 11.1M 2024-12
Baxter International USD 615M 16M 2024-12
Bayer EUR 4.34B 610M 2024-12
Biogen USD 677.3M 99.6M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Insmed USD 142.51M 23.58M 2024-12
Intra Cellular Therapies USD 137.73M 5.63M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
J&J USD 6.45B 975M 2024-12
Moderna USD 351M 70M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
PTC Therapeutics USD 84.68M 11.23M 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
United Therapeutics USD 162.5M 8.4M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



United Therapeutics Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.